#amgen inc | Explore Tumblr Posts and Blogs

whereserpentswalk · 15 days

Text

Your body will transform to fit the world you go to, and you can choose for time to pass slower on your original world. There's a good chance you'll end up dating (and probably fucking) the creature you with if that's the thing you're into. You can still contact them after you go back home.

Reblog to get them to appear swiftly. Like to give them a little treat on their way there.

520 notes · View notes

widows-and-orphans-united · 3 months

Text

One Chance to Create an Impact: The Power of Compassion

In a world rife with challenges and adversities, it is easy to feel overwhelmed and helpless. However, amidst these challenges lies a powerful truth – every individual holds the potential to bring about significant change within them.

One Chance to Create an Impact: The Power of Compassion In a world rife with challenges and adversities, it is easy to feel overwhelmed and helpless. However, amidst these challenges lies a powerful truth – every individual holds the potential to bring about significant change within them. It begins with recognizing that we are not just passive observers but active participants who can make a…

View On WordPress

0 notes

amgenclassactionlawsuit · 1 year

Text

Contact an Amgen stock loss lawyer today about an Amgen class action lawsuit. 855-Tim-MLaw

#Amgen Inc. Class Action Lawsuit #Amgen Class Action Lawsuit #suffered losses in Amgen stock #Amgen stock loss lawyer #ts4

1 note · View note

industryinsightsandanalysis · 2 days

Text

Uveitis Treatment Market Trend and Future Outlook

The Uveitis Treatment Market is projected to witness a CAGR of around 6% during the forecast period. Uveitis, an inflammation of the uvea (the middle layer of the eye), can cause symptoms such as redness, pain, light sensitivity, blurred vision, and dark floating spots. It can be triggered by infections, injuries, or autoimmune/inflammatory diseases, and can lead to permanent vision loss if not treated promptly. Early diagnosis and treatment are therefore crucial to prevent serious complications and preserve vision. According to an article by the Ocular Immunology and Uveitis Foundation in April 2022, uveitis affects 109,000 people in the U.S. annually, with 43,000 new cases diagnosed each year. Consequently, the uveitis treatment market is expected to grow steadily during the forecast period.

Impact of COVID-19

The COVID-19 pandemic initially impacted the uveitis treatment market due to lockdowns and movement restrictions worldwide. Ophthalmology practices were significantly curtailed, allowing only urgent procedures. However, as COVID-19 cases declined in late 2020, healthcare providers and patients began to resume treatments, leading to a recovery and steady growth in the uveitis treatment market.

For a comprehensive analysis of the market drivers, visit: https://univdatos.com/report/uveitis-treatment-market/

Market Segmentation

By Drug Class

The market is segmented into anti-inflammatory drugs, antimicrobial drugs, immunotherapy & targeted therapies, and others. The anti-inflammatory category is expected to see significant growth due to increasing cases of non-infectious eye diseases. Major players are also focusing on developing and launching new drugs for uveitis treatment. For example, in March 2022, Bausch + Lomb and Clearside Biomedical launched "Xipere" (triamcinolone acetonide injectable suspension) for macular edema associated with uveitis in the U.S.

By Disease Type

The market is categorized into anterior uveitis, posterior uveitis, intermediate uveitis, and pan uveitis. The anterior uveitis segment is anticipated to grow significantly due to the high risk of untreated anterior uveitis leading to vision loss, cataracts, glaucoma, or retinal edema, coupled with the aging population. According to the World Health Organization (WHO), approximately 253 million people globally have vision impairment, with 36 million being blind and 217 million having moderate or severe vision impairment.

By Distribution Channel

The market is divided into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to grow significantly due to the treatment of various eye diseases and conditions, such as cataracts and autoimmune illnesses, primarily being conducted in hospitals. According to the United Nations, the elderly population (60+) was 962 million in 2017 and is expected to double by 2050, reaching nearly 2.1 billion.

Regional Insights

The report provides detailed regional analysis, covering North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, Rest of Asia-Pacific), and the Rest of the World. North America held a significant market share in 2020 due to the increasing patient pool, rising cases of cystoid macular edema, and autoimmune & inflammatory illnesses. The region benefits from high healthcare spending, supportive reimbursement policies, and advanced healthcare infrastructure.

For a sample report, visit: https://univdatos.com/get-a-free-sample-form-php/?product_id=22860

Key Market Players

Major companies in the uveitis treatment market include AbbVie Inc., Alimera Sciences Inc., Allergan Plc., Amgen Inc., Bausch Health Companies Inc., Clearside Biomedical Inc., EyePoint Pharmaceuticals Inc., Mylan N.V., Novartis AG, and Santen Pharmaceutical Co. Ltd. These companies are engaged in various mergers, acquisitions, and partnerships to develop new treatments for uveitis.

Contact Us:

UnivDatos Market Insights

Email - [email protected]

Contact Number - +1 9782263411

Website -www.univdatos.com

#Uveitis Treatment Market #Uveitis Treatment Market Size #Uveitis Treatment Market Report #Uveitis Treatment Market Forecast

0 notes

marketdigitsinsights · 3 days

Text

0 notes

bhushans · 4 days

Text

Meeting the Needs of a Growing Population: The Evolving Global Drug Formulation Market

The global Drug Formulation market is projected to increase between 2022 and 2032 at a compound annual growth rate of 5.6%. Sales of medication formulations are predicted to reach USD 1.58 trillion by 2022. The study projects that during the forecast period, oral formulations would develop at an exponential rate, with a compound annual growth rate of 6.0%.

Enhance Research With a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15755

The worldwide drug formulation market is crucial to the pharmaceutical industry because it facilitates the transformation of active pharmaceutical ingredients (APIs) into finished pharmaceuticals that are safe for ingestion by humans. The expected growth is due to both the growing demand for pharmaceutical items and advancements in medicine formulation technology.

Key Takeaways:

The global drug formulation market is expected to reach US$2.87 trillion by 2032, growing at a CAGR of 5.6%.

Oral formulations are projected to experience the fastest growth, with a CAGR of 6.0% during the forecast period.

Rising demand for innovative drug delivery systems and growing healthcare needs worldwide are key drivers.

Competitive Landscape:

In the medication formulation industry, major players are employing methods such as advanced product launches through approvals and mergers and acquisitions. The major businesses are concentrating on working with the research institutes to gain a competitive edge in the marketplace.

A definitive merger agreement between Bristol Myers Squibb and Turning Point Therapeutics was signed on June 20, 2022. This acquisition will expand BMS’s selection of oncology drugs because Turning Point Therapeutics is a precision oncology company that is still in the clinical development stage.

AstraZeneca introduced The Evusheld long-acting antibody combo to the public on March 20, 2022. For the pre-exposure prophylaxis (prevention) of COVID-19 in a sizable population, it has received authorization in Europe.

Key Companies Profiled:

AstraZeneca plc.

Bristol-Myers Squibb

Eli Lilly and Company

Gilead Sciences, Inc.

Merck & Co., Inc.

Novartis AG

Pfizer Inc.

AbbVie Inc.

Boehringer Ingelheim International GmbH

F. Hoffmann-La Roche AG

Johnson & Johnson

3M Company

Bayer AG

Teva Pharmaceuticals Industries Ltd.

Amgen, Inc.

Sanofi SA

GlaxoSmithKline plc

Boston Scientific Corporation

Gerresheimer AG

Nimbus Therapeutics

Antares Pharma, Inc.

IDEAYA Biosciences, Inc.

Key Market Segments Covered in Drug Formulation Industry Research:

By Dosage Form:

Oral formulations

Tablets

Immediate Release

Modified Release

Chewable

Effervescent

Capsules

Hard Gelatin Capsules

Softgel Capsules

Others

Powders & Granules

Lozenges & Pastilles

Gummies

Others

Parenteral formulations

Solutions

Suspensions

Emulsions for injection or infusion

Powders for injection or infusion

Gels for injection implants

Topical formulations

Pastes

Ointments and oils

Creams, lotions, and foams.

Gels, tinctures, and powders

Sprays and patches

Inhalation formulations

Pressurized Metered Dose Inhaler

Dry Powder Inhaler (DPI)

Nebulizer

By Indication:

Infectious Diseases

Cancer

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Central Nervous System Disorders

Autoimmune Diseases

Gastrointestinal Diseases

Musculoskeletal Disorders

Dermatological Disorders

Other

By End User:

Big pharma

Small & Medium Size Pharma

Biotech Companies

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

The Middle East and Africa (MEA)

#Drug Formulation Market

0 notes

anveshanblog · 4 days

Text

Global Regenerative Medicine Market at value of USD 70.11 billion

Forecasted for 2024 to 2028, the regenerative medicine sector is anticipated to surge to a valuation of USD 70.11 billion, soaring at a notable CAGR of 23.31% within the years 2023 to 2028. This growth trajectory is primarily propelled by the increasing prevalence of chronic diseases worldwide, necessitating groundbreaking therapies and remedies to effectively combat these enduring health conditions. As the demand for innovative treatments intensifies amidst the persistent challenge of chronic illnesses, various industries are compelled to invest in research and development efforts to meet the evolving healthcare needs of individuals.

Regenerative Medicine Market Forecast and Dimensions Influenced by factors such as platelet-rich plasma, TRIM72 protein, and advancements in vasculature development, the global regenerative medicine market is witnessing rapid expansion, bolstered by burgeoning research grants and the emergence of innovative pipeline candidates. Notably, cell therapy, particularly in domains like skeletal muscles and vasculature, is gaining prominence, with companies like CellPoint spearheading the development of novel cell therapy solutions.

Download Global Regenerative Medicine Market Sample PDF Report

Market Segmentation and Dynamics The regenerative medicine market is characterized by a dynamic landscape spanning various domains, including blood cancers, rare diseases, and chronic genetic disorders. Advancements in personalized medicine, gene therapy, and CRISPR therapy are driving transformative changes, with key players like Metcela Inc, Integra LifeSciences, and ACell, Inc leading the charge in developing innovative cellular therapies and tissue engineering solutions. Strategic initiatives such as mergers, research collaborations, and partnerships are further fostering the development of groundbreaking treatments like CAR-T treatment and gene therapy.

The market segmentation, comprising applications, technology, and geography, underscores a thriving ecosystem fueled by healthcare expenditure, governmental support, and a robust pipeline of innovative candidates across therapeutic areas.

Regional Contribution and Market Trends North America is poised to make a significant contribution to global market growth, with factors such as rising incidence of chronic and acute diseases, a rapidly aging populace, and heightened awareness of regenerative therapies driving expansion. In the APAC region, markets like Japan are shaping the global landscape, indicating a widespread acceptance and adoption of regenerative medicine.

Emerging Trends and Challenges The rising significance of CAR-T therapies and the increasing complexity of regenerative medicine products are notable trends and challenges shaping market dynamics. While CAR-T therapies demonstrate remarkable potential in targeting and eliminating cancer cells, the complexity of regenerative products, coupled with insufficient regulatory frameworks and reimbursement issues, poses significant hurdles to market growth.

Key Players and Market Analyst Overview Key companies such as AbbVie Inc., Amgen Inc., and Johnson and Johnson are implementing various strategies to enhance their market presence, including strategic alliances, mergers, and product launches. The market is witnessing continuous innovation, with a focus on addressing conditions like blood cancers, rare diseases, and chronic genetic disorders.

Segment Overview and Conclusion The regenerative medicine market research report provides comprehensive data and forecasts, highlighting the sector's growth potential and evolving dynamics across various segments. From advancements in personalized medicine to the exploration of gene-based therapy and stem cells, regenerative medicine continues to revolutionize healthcare, offering hope for addressing age-related disorders and enhancing patient outcomes across diverse therapeutic areas.

Download Global Regenerative Medicine Market Sample PDF Report

0 notes

rajul123 · 5 days

Text

Regenerative Medicine Market by Size, Share, Forecasts, & Trends Analysis

Meticulous Research®, a prominent international market research firm, recently released a report titled Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, PRP, CAR T Cell, Tissue Engineering) Application (Oncology, Cardiovascular, Neurology, Immunology) End User (Hospital, ASC) — Global Forecast to 2031.

As per the most recent report by Meticulous Research®, the regenerative medicine market is anticipated to achieve a value of $78.53 billion by 2031, growing at a compound annual growth rate (CAGR) of 20% between 2024 and 2031. This expansion is attributed to several factors including the growing number of approvals for regenerative medicine, advancements in this field, a rise in the incidence of diseases targeted by these therapies, broader applications of regenerative medicine across various therapy areas, and increased funding for research and development. Nonetheless, challenges such as the high treatment costs and ethical considerations associated with stem cell usage could pose constraints on market growth.

Additionally, the growing interest in personalized medicine, escalating demand for organ transplants, and the expanding pipeline of products are anticipated to offer opportunities for market expansion. However, obstacles such as unfavorable reimbursement policies and manufacturing complexities are hindering the market's growth.

Key Players

The regenerative medicine market is populated by prominent players including Novartis AG (Switzerland), Biogen Inc. (U.S.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Integra Life Sciences (U.S.), Sarepta Therapeutics, Inc. (U.S.), Bayer AG (Germany), Amgen Inc. (U.S.), CORESTEMCHEMON Inc. (South Korea), Smith & Nephew plc (U.K.), GSK plc (U.K.), Takeda Pharmaceutical Company Limited (Japan), Astellas Pharma (Japan), Medtronic plc (Ireland), AbbVie Inc. (U.S.), Bristol Myers Squibb (U.S.), Cook Group Incorporated (U.S.), Pfizer Inc. (U.S.), Merck KGaA (Germany), and Vericel (U.S.).

Regenerative Medicine Market: Future Outlook

The regenerative medicine market is categorized based on product types such as gene therapy, cell therapy (including stem cell therapy, platelet-rich plasma therapy, and cell-based immunotherapy), and tissue engineering. It is further segmented by applications including cardiovascular diseases, ophthalmic diseases, oncology, neurological diseases, immunology & inflammation, musculoskeletal diseases, dermatological diseases, and other applications. Additionally, the market is segmented by end users into hospitals & clinics and ambulatory surgical centers. The study thoroughly assesses competitors in the industry and provides analysis at both global and regional levels.

Among the products covered in this report, the gene therapy sector is forecasted to experience the highest growth rate from 2024 to 2031. This growth is driven by the increasing adoption of gene therapies in the treatment of various diseases like cancer, immunodeficiency disorders, cystic fibrosis, and diabetes. Gene therapy involves the introduction of new copies of a defective gene or the replacement of a faulty gene entirely. Advancements in genetic engineering technologies, such as CRISPR CAS, are further enhancing the efficacy of gene therapy by enabling precise genome alterations in a shorter timeframe. For example, the U.K. government has approved the use of CRISPR–Cas9 gene editing therapy for sickle cell anemia treatment. Additionally, there's a notable focus from manufacturers on developing gene therapy products. According to data from the Alliance for Regenerative Medicine, as of the third quarter of 2023, 556 manufacturers in North America and 209 in Europe were actively involved in the development of gene therapy products.

Among the applications covered in this report, in 2024, the oncology segment is expected to dominate the regenerative medicine market. This dominance is driven by several factors, including the significant global burden of cancer, a rising research emphasis on using regenerative medicine for cancer treatment, increasing approvals of regenerative medicine products specifically for oncology applications, a growing number of clinical trials in this area, and the escalating public-private funding aimed at advancing oncology treatments. For example, in March 2023, researchers at the University of California were granted a USD 5.7 million from the California Institute of Regenerative Medicine to support their efforts in advancing stem cell therapy for cancer treatment.

Among the end users covered in this report, by 2024, the hospitals & clinics segment is forecasted to hold the majority share of the regenerative medicine market. This dominance can be credited to several factors, including the growing number of both public and private hospitals, the rising incidence of chronic diseases resulting in increased hospital admissions, and the expanding availability of regenerative medicine therapies within hospital settings. Furthermore, the existence of reimbursement policies for regenerative medicine procedures performed at hospitals adds to the segment's significant market share.

Geographic Review:

The research report examines key geographical regions and offers a thorough analysis of the market across various areas including North America (comprising the U.S. and Canada), Europe (encompassing Germany, France, the U.K., Italy, Spain, Switzerland, Netherlands, Sweden, and the Rest of Europe), Asia-Pacific (including China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), Latin America (comprising Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.

Among the regions analyzed in this report, the Asia-Pacific market is anticipated to demonstrate the most significant growth rate throughout the forecast period. This growth is fueled by proactive government efforts aimed at fostering the development of regenerative medicine and by increased funding for research endeavors. Governments in countries like India, Australia, and South Korea are actively offering research grants to bolster advancements in regenerative medicine, thereby fostering opportunities for market expansion. As an example, India's Department of Biotechnology allocated a fund of USD 9.35 million over a four-year period from 2019 to 2022 to support research in this domain.

Additionally, the affordability of stem cell therapy in nations like India, in contrast to North America and Europe, is drawing medical tourists and stimulating the demand for regenerative medicine. According to reports from Medical Tourism Corporation in India, the cost of stem cell therapy in the country is roughly 25% lower than that in Western nations, rendering it a more cost-effective choice for patients in need of such treatments.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5864

Key questions answered in the report-

What are the market segments showing significant growth potential in terms of product, application, end user, and region/country?

What was the past global market size of the regenerative medicine market?

What are the projected market forecasts and estimations for the period spanning from 2024 to 2031?

What are the primary factors propelling, hindering, challenging, offering opportunities, and shaping trends within the regenerative medicine market?

Who are the key players in the regenerative medicine market?

What does the competitive scenario look like, and who are the leading players in the regenerative medicine market?

What are the latest advancements or updates in the regenerative medicine market?

What are the various approaches employed by the key players in the regenerative medicine market?

What are the trends observed in different geographical regions and which regions or countries show significant growth potential?

Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

#Regenerative Medicine Market #Regenerative Therapy #Tissue Engineering #Stem Cell #CAR T Cell #Stem Cell Therapy #Regenerative Biology #Cell Therapy Market

0 notes

datahorizzon-research1 · 12 days

Text

T Cell Therapy Market Size was valued at USD 3.8 Billion in 2023 and is expected to reach a market size of USD 49.9 Billion by 2032

The T cell therapy market size was valued at USD 3.8 Billion in 2023 and is expected to reach a market size of USD 49.9 Billion by 2032 at a CAGR of 32.9%.

Request Sample Report: https://datahorizzonresearch.com/request-sample-pdf/t-cell-therapy-market-3114

Top Companies are:

· Novartis AG

· Gilead Sciences, Inc.

· Bristol-Myers Squibb Company

· Adaptimmune Therapeutics plc

· Amgen Inc.

· Atara Biotherapeutics, Inc.

· Autolus Therapeutics plc

· bluebird bio, Inc.

· Cellectis S.A.

· Iovance Biotherapeutics, Inc.

· Kite Pharma (a Gilead Company)

· Tmunity Therapeutics, Inc.

Market Segmentations:

By Type-

CAR T cell therapy

TCR T cell therapy

TIL (Tumor-infiltrating lymphocyte) therapy

Others

By Application-

Lymphoma

Leukemia

Multiple myeloma

Melanoma

Lung cancer

Breast cancer

Colorectal cancer

Autoimmune disorders

Infectious diseases

Others

By End User-

Hospitals and Clinics

Cancer research centers

Others

Regional Analysis:

The dominance of the T Cell Therapy market in North America is underpinned by the presence of established biopharmaceutical firms, a robust clinical trial infrastructure, and a favorable regulatory landscape. Among North American countries, the United States stands out as the primary contributor, buoyed by the FDA’s approval of several CAR T cell therapies such as Kymriah, Yescarta, and Abecma for treating hematological malignancies. The U.S. National Library of Medicine’s database reveals an extensive presence of over 1,000 active clinical trials dedicated to evaluating T cell therapies, underscoring the region’s steadfast commitment to research and development in this field.

Key highlights of the report include:

1. The report delivers thorough Market analysis, furnishing valuable insights to guide strategic decision-making.

2. The comprehensive research outlined in the study enhances the depth of your presentations and marketing strategies.

3. By offering crucial insights into key market competitors, the study empowers businesses with a strategic edge.

4. It delivers a precise assessment of evolving market dynamics, ensuring readers stay abreast of the latest industry trends.

5. With meticulous breakdowns of various market niches, the report facilitates informed decision-making processes.

0 notes

widows-and-orphans-united · 4 months

Text

Seeking Corporate Sponsorship: A Mission to Transform Lives Together

I represent Widows and Orphans, a nonprofit organization dedicated to a noble and transformative mission. We stand at the forefront of a unique initiative, blending care for the elderly with support for foster children under one umbrella.

Seeking Corporate Sponsorship: A Mission to Transform Lives Together Greetings, valued readers and potential partners in progress! I write enthusiastically and purposefully, addressing forward-thinking corporations who aspire to make a real difference. I represent Widows and Orphans, a nonprofit organization dedicated to a noble and transformative mission. We stand at the forefront of a unique…

View On WordPress

0 notes

simranmakhija1 · 16 days

Text

Global Perspective: Regional Markets and Emerging Trends in Protein Engineering

The Protein Engineering Market is witnessing significant growth driven by advancements in biotechnology, increased understanding of protein structure-function relationships, and the growing demand for novel protein-based therapeutics, enzymes, and biologics. Protein engineering, a multidisciplinary field that combines principles of molecular biology, biochemistry, and computational biology, focuses on modifying and designing proteins to enhance their properties, functions, and applications.

Get a free Sample: https://www.marketdigits.com/request/sample/3795

One of the primary drivers of market growth is the rising demand for protein-based drugs and biologics for the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases. Protein therapeutics, such as monoclonal antibodies, cytokines, and growth factors, offer targeted and specific modes of action, with reduced side effects compared to traditional small molecule drugs. As a result, pharmaceutical companies and biotech firms are increasingly investing in protein engineering technologies to develop next-generation biologics with improved efficacy, pharmacokinetics, and safety profiles.

The Protein Engineering Market is Valued USD 2.49 billion in 2024 and projected to reach USD 6.35 billion by 2030, growing at a CAGR of CAGR of 14.3% During the Forecast period of 2024-2032.

Furthermore, protein engineering plays a critical role in enzyme engineering and industrial biotechnology applications. Engineered enzymes are used in various industrial processes, including biofuel production, food processing, and biocatalysis, to improve efficiency, yield, and sustainability. Protein engineering techniques, such as directed evolution, rational design, and computational protein design, enable researchers to optimize enzyme properties, such as substrate specificity, stability, and catalytic activity, for specific industrial applications.

The protein engineering market is characterized by the presence of a diverse range of technologies and products, including protein design software, expression systems, purification methods, and screening assays. Major players in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Codexis, Inc., GenScript Biotech Corporation, and Abcam plc, among others. These companies offer comprehensive solutions for protein engineering, from gene synthesis and expression to protein purification and characterization, catering to the needs of academic research labs, biotech startups, and pharmaceutical companies worldwide.

Major vendors in the global Protein Engineering Market: Agilent Technologies, Bruker Cor., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp., Amgen, Inc. and Others

Emerging trends in the protein engineering market include the development of novel protein engineering platforms, such as CRISPR-based protein engineering, machine learning algorithms, and computational protein design tools. CRISPR technology, originally developed for genome editing, has been adapted for protein engineering applications, enabling precise modifications of protein sequences and structures. Machine learning algorithms analyze large datasets of protein sequences and structures to predict protein function, stability, and interactions, facilitating rational protein design and optimization. Computational protein design tools simulate protein folding and dynamics to predict protein structures and engineer proteins with desired properties.

Looking ahead, the protein engineering market is poised for continued growth driven by ongoing technological advancements, increasing adoption of protein-based therapeutics, and the growing demand for sustainable biomanufacturing solutions. As researchers continue to refine protein engineering techniques, optimize protein design algorithms, and expand the applications of engineered proteins, protein-based drugs and biologics will play an increasingly important role in personalized medicine, industrial biotechnology, and environmental sustainability. Collaborations between industry stakeholders, academic institutions, and regulatory agencies will be essential in driving innovation, establishing quality standards, and ensuring the safe and effective translation of protein engineering technologies into clinical and commercial applications.

0 notes

fmarkets · 21 days

Text

$ #SP500 #NASDAQ #SPX $ETN-USD

Date: May 3, 2024 In a remarkable turn of events, the stock market witnessed a highly optimistic trading day on Friday, May 3, 2024. With stocks in the Movies and Entertainment industry and Personal Services industry experiencing significant gains, market indices soared after Thursday's impressive performance. Additionally, favorable reports from the U.S. Department of Labor regarding April's Employment Situation exerted a major influence on stock market indices. The Movies and Entertainment industry took center stage as stocks in this sector surged by 8.02%. Live Nation Entertainment Inc (LYV) stood out with an incredible 9.82% increase, elevating the industry as a whole. Similarly, Personal Services stocks saw a rise of 4.08%, with Booking Holdings Inc (BKNG) leading the way by surging 4.82%. Meanwhile, the Biotechnology and Pharmaceuticals industry demonstrated strong performance, with a 3.44% increase. The impressive gains were primarily driven by Amgen Inc (AMGN), which soared by an astonishing 12.94%, and Biogen Inc (BIIB), which en https://csimarket.com/news/news_markets.php?date=2024-05-03T17215&utm_source=dlvr.it&utm_medium=tumblr

#News #StockMarket #StockTrading #StockMarketsToday #Electroneum

0 notes

rohanisblog · 22 days

Text

Global Dermatology Drugs Market was valued at US$ 18.42 billion in 2022 and is estimated to reach a valuation of US$ 45.35 billion and 79.24 metric ton in terms of volume by 2031. The market is anticipated to grow at a CAGR of 11.0% during the forecast period 2023-2031.

List of Key Companies Profiled

Amgen Inc

Bausch Health Companies Inc.

Botanix Pharmaceuticals

Bristol-Myers Squibb Company

Eli Lilly and Company

Johnson & Johnson

LEO Pharma A/S

Merck KGaA

Mylan N.V.

Novartis AG

Pfizer Inc.

Other Prominent Players

#Dermatology Drugs Market #Size #Share #Trends

0 notes

delvenservices · 1 month

Text

Immunotherapy Drugs Market to Witness Huge Growth by 2030

Immunotherapy Drugs Market research report deals with many parameters in depth to satisfy the requirements of business or clients. Moreover, it also displays all the information including market definition, classifications, key developments, applications, and engagements along with the detailed actions of key players with respect to product launches, joint ventures, developments, mergers and acquisitions and effects of the same in terms of sales, import, export, revenue and CAGR values. A team of experienced and consummate market research professionals persistently track key industries to spot key developments, unmet needs and possible growth opportunities.

Immunotherapy Drugs Market, By Drug Type (Monoclonal Antibodies, Immunomodulators), By Indication (Infectious Diseases, Cancer) and by Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The global Immunotherapy Drugs Market size is projected to reach a CAGR of 11.7% from 2023-2030.

Download Free Sample Report at: https://www.delvens.com/get-free-sample/immunotherapy-drugs-market

Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the immune system of the body and generating an immune response aiding the production of antibodies. Antibodies produced against antigens kill the cancerous or tumour cells.

The global immunotherapy market is driven by the increasing adoption of targeted therapies, the increase in the life span of patients, and the high prevalence of lifestyle diseases. Furthermore, rapid approval of drugs and reduction in the recurrence of diseases propel market growth. Additionally, immunotherapy as an alternative to chemotherapy and the use of immunotherapy as the first line of drug for the treatment of cancer provide growth opportunities for the market players shortly.

Immunotherapy Drugs Market Competitive Landscape:

Amgen, Inc.

Novartis AG

AbbVie, Inc.

Pfizer, Inc.

F. Hoffmann-La Roche Ltd.

Johnson & Johnson Services, Inc.

AstraZeneca

GSK

Sanofi

Bayer AG

Immunotherapy Drugs Market Recent Developments:

August 29, 2022 - AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV).

August 24, 2022 - AbbVie announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA® (ibrutinib) for the treatment of paediatric patients one year and older with chronic graft versus host disease (cGVHD) after the failure of one or more lines of systemic therapy.

Immunotherapy Drugs Market Key Findings:

Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the immune system of the body and generating an immune response aiding the production of antibodies. Antibodies produced against antigens kill the cancerous or tumour cells.

The indication segment is further fragmented into Cancer, Autoimmune Diseases, Infectious Diseases, and Others. The cancer segment accounted for the largest revenue share owing to the increased prevalence of cancer, coupled with a rise in the launch of cancer immunotherapies.

The drug type segment is further fragmented into monoclonal antibodies, immunomodulators, and vaccines. The monoclonal antibodies segment accounted for the largest share owing to increased R&D in therapeutic monoclonal antibodies coupled with supportive government initiatives.

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America dominated the global industry and accounted for the largest share of the overall revenue. The launch and regulatory approval of new immunotherapy drugs and favourable reimbursement policies are projected to aid in the region’s growth.

Immunotherapy Drugs Market Regional Analysis:

North America to Dominate the Market

North America dominated the global industry and accounted for the largest share of the overall revenue.

The launch and regulatory approval of new immunotherapy drugs and favourable reimbursement policies are projected to aid in the region’s growth.

Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/immunotherapy-drugs-market

Scope of the Immunotherapy Drugs Market Report:

Immunotherapy Drugs Market is segmented into various segments such as drug type, indication, and region:

On the basis of drug type

Monoclonal Antibodies

Immunomodulators

Vaccines

On the basis of the indication

Cancer

Autoimmune Diseases

Infectious Diseases

Others

On the basis of region

Asia Pacific

North America

Europe

South America

Middle East & Africa

Frequently Asked Questions:

What are the years considered to study Immunotherapy Drugs Market?

What is the compound annual growth rate (CAGR) of the Immunotherapy Drugs Market?

Which region holds the largest market share in Immunotherapy Drugs Market?

Who are the major players in Immunotherapy Drugs Market?

Direct Purchase of the Immunotherapy Drugs Market Research Report at: https://www.delvens.com/checkout/immunotherapy-drugs-market

Browse Related Reports:

RNA-Sequencing (RNA-seq) & Analysis Market

Prostate Cancer Therapeutics Market

Relapsed/Refractory Multiple Myeloma (RRMM) Market

Genetic Testing Market

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

[email protected]

#consulting company #strategic advisory firm #best market reports #market analysis reports #trending reports #syndicated reports #Immunotherapy Drugs Market #Immunotherapy Drugs #Pharmaceutical #pharmaindustry

0 notes

datahorizzon-research1 · 22 days

Text

Bone Metastasis Treatment Market size to Reach USD 38.5 billion by 2032

The bone metastasis treatment market size was valued at USD 21.4 Billion in 2023 and is expected to reach a market size of USD 38.5 Billion by 2032 at a CAGR of 6.8%.

The bone metastasis treatment market is witnessing significant growth owing to the rising incidence of cancer and subsequent metastasis to the bones. Bone metastasis occurs when cancer cells from the primary tumor spread to the bones, leading to severe complications such as bone pain, fractures, and spinal cord compression.

Request Sample Report: https://datahorizzonresearch.com/request-sample-pdf/bone-metastasis-treatment-market-3128

Recent developments in the bone metastasis treatment market include:

Advancements in Radiation Therapy: Innovations in radiation therapy techniques such as stereotactic body radiation therapy (SBRT) and intensity-modulated radiation therapy (IMRT) are improving treatment precision and efficacy while minimizing damage to surrounding healthy tissues.

Emerging Targeted Therapies: Novel targeted therapies, including monoclonal antibodies and kinase inhibitors, are being developed to specifically target molecular pathways involved in bone metastasis, offering promising results in clinical trials.

Immunotherapy Approaches: Immunotherapeutic agents such as immune checkpoint inhibitors are being investigated for their potential in treating bone metastasis by enhancing the body’s immune response against cancer cells.

Development of Bone-Targeted Agents: Pharmaceutical companies are focusing on the development of bone-targeted agents such as RANK ligand inhibitors and radiopharmaceuticals to prevent skeletal-related events and improve outcomes for patients with bone metastasis.

Personalized Medicine: Advances in genomics and molecular profiling are enabling personalized treatment approaches, allowing healthcare providers to tailor therapies based on the unique characteristics of each patient’s cancer.

Top Companies are:

· Amgen Inc.

· Bayer AG

· Merck & Co., Inc.

· Novartis AG

· Pfizer Inc.

· Roche Holding AG

· Johnson & Johnson

· Bristol-Myers Squibb Company

· AstraZeneca PLC

· Eli Lilly and Company

· Takeda Pharmaceutical Company Limited

· Sanofi

Market Segmentations:

By Therapy Type (2024–2032)

Chemotherapy

Hormone Therapy

Targeted Therapy

Immunotherapy

External Beam Radiation Therapy (EBRT)

Others

By End User (2024–2032)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Others

Regional Analysis:

North America stands as the leading regional hub for Bone Metastasis Treatment, with the United States emerging as a dominant force within this market. This supremacy is propelled by several factors, including the nation’s high prevalence of cancer, its sophisticated healthcare infrastructure, and substantial healthcare expenditure.

According to the American Cancer Society’s data for 2023, an estimated 1,958,310 new cancer cases are projected to be diagnosed in the United States, with approximately 609,820 individuals succumbing to the disease. The National Cancer Institute (NCI) further underscores that the spine, pelvis, ribs, and long bones of the extremities remain the most common sites for bone metastases.

Key highlights of the report include:

1. The report delivers thorough Market analysis, furnishing valuable insights to guide strategic decision-making.

2. The comprehensive research outlined in the study enhances the depth of your presentations and marketing strategies.

3. By offering crucial insights into key market competitors, the study empowers businesses with a strategic edge.

4. It delivers a precise assessment of evolving market dynamics, ensuring readers stay abreast of the latest industry trends.

5. With meticulous breakdowns of various market niches, the report facilitates informed decision-making processes.

0 notes

businessindustry · 1 month

Text

Molecular Glues Market Application, Growth 2024-2032

The Reports and Insights, a leading market research company, has recently releases report titled “Molecular Glues Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Molecular Glues Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Molecular Glues Market?

According to Reports and Insights analysis, the global molecular glues market is expected to register a revenue CAGR of 5.8% during the forecast period of 2024-2032.

What are Molecular Glues?

Molecular glues are small molecules capable of binding to two different proteins simultaneously, thereby effectively "gluing" them together. This characteristic enables them to modulate interactions between proteins, influencing various cellular functions. Molecular glues have garnered considerable interest in drug discovery and development because they can target protein complexes that are difficult to inhibit using conventional methods. They present a promising strategy for creating new treatments for diseases like cancer, neurodegenerative disorders, and viral infections, by selectively targeting specific protein interactions crucial for the advancement of these conditions.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/1609

What are the growth prospects and trends in the Molecular Glues industry?

The molecular glues market growth is driven by various factors. The molecular glues market is experiencing significant growth, primarily due to the increasing emphasis on drug discovery and development. Molecular glues are essential for modulating interactions between proteins, making them invaluable in addressing complex diseases. Factors such as the rising incidence of chronic diseases, growing demand for targeted therapies, and advancements in molecular biology are propelling market expansion. Moreover, the rising investment in research and development focused on molecular glues is expected to drive further market growth. Hence, all these factors contribute to molecular glues market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Product Type:

Proteolysis-Targeting Chimeras (PROTACs)

Specific and Nongeneric Protein Degraders

Other Molecular Glues

Application:

Oncology

Genetic Disorders

Neurological Disorders

Infectious Diseases

Other Therapeutic Areas

End-user:

Pharmaceuticals and Biotechnology Companies

Research Institutes and Academia

Contract Research Organizations (CROs)

Others

Research Focus:

Preclinical Studies

Clinical Trials

Post-market Surveillance

Segmentation By Region:

North America:

United States

Canada

Europe:

Germany

The U.K.

France

Spain

Italy

Russia

Poland

BENELUX

NORDIC

Rest of Europe

Asia Pacific:

China

Japan

India

South Korea

ASEAN

Australia & New Zealand

Rest of Asia Pacific

Latin America:

Brazil

Mexico

Argentina

Middle East & Africa:

Saudi Arabia

South Africa

United Arab Emirates

Israel

Who are the key players operating in the industry?

The report covers the major market players including:

Arvinas Inc.

C4 Therapeutics

Kymera Therapeutics

Nurix Therapeutics

Bristol Myers Squibb

Boehringer Ingelheim

AstraZeneca

Genentech (a member of the Roche Group)

GlaxoSmithKline

Novartis

Pfizer Inc.

Takeda Pharmaceuticals

Merck & Co., Inc.

Amgen Inc.

Vertex Pharmaceuticals

View Full Report: https://www.reportsandinsights.com/report/Molecular Glues-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: [email protected] Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

#Molecular Glues Market share #Molecular Glues Market size #Molecular Glues Market trends

0 notes